These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16194413

  • 41. An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension.
    Karnik ND, Oza YK, Sane SP, Kaushik R, Bhatt AD, Chawla KP, Vaidya AB, Yajnik VH, Khokhani RC.
    J Assoc Physicians India; 1998 Mar; 46(3):283-5. PubMed ID: 11273348
    [Abstract] [Full Text] [Related]

  • 42. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 43. An open-label, randomized, controlled, 4-week comparative clinical trial of barnidipine hydrochloride, a calcium-channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor, in Chinese patients with renal parenchymal hypertension.
    Chen X, Zheng F, Chen P, Tang L, Wei R, Yu Y, Su Y, Kikkawa T, Yamamoto M.
    J Int Med Res; 2006 Feb; 34(2):121-8. PubMed ID: 16749407
    [Abstract] [Full Text] [Related]

  • 44. A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs.
    Tenhündfeld J, Wefstaedt P, Nolte IJ.
    J Am Vet Med Assoc; 2009 Apr 15; 234(8):1031-7. PubMed ID: 19366333
    [Abstract] [Full Text] [Related]

  • 45. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease.
    van de Ven PJ, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Koomans HA.
    Kidney Int; 1998 Apr 15; 53(4):986-93. PubMed ID: 9551408
    [Abstract] [Full Text] [Related]

  • 46. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL, Weir MR.
    Arch Intern Med; 2000 Mar 13; 160(5):685-93. PubMed ID: 10724055
    [Abstract] [Full Text] [Related]

  • 47. Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD).
    Morita S, Fukuhara S, Akizawa T, Asano Y, Kurokawa K.
    Clin Exp Nephrol; 2005 Sep 13; 9(3):219-27. PubMed ID: 16189630
    [Abstract] [Full Text] [Related]

  • 48. [Treatment of stage 3b diabetic kidney disease patients with macroalbuminuria by qizhi jiangtang capsule: a multicenter randomized control clinical study].
    Guo ZA, Yu CJ, Liu G, Meng FC, Li Y, Peng SL.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep 13; 34(9):1047-52. PubMed ID: 25335326
    [Abstract] [Full Text] [Related]

  • 49. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL, Pitt B, Weir MR, Freeman MW, Mayo MR, Garza D, Stasiv Y, Zawadzki R, Berman L, Bushinsky DA, AMETHYST-DN Investigators.
    JAMA; 2015 Jul 14; 314(2):151-61. PubMed ID: 26172895
    [Abstract] [Full Text] [Related]

  • 50. Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy.
    Suzuki H, Kanno Y, Ikeda N, Nakamoto H, Okada H, Sugahara S.
    Hypertens Res; 2002 Nov 14; 25(6):865-73. PubMed ID: 12484510
    [Abstract] [Full Text] [Related]

  • 51. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
    Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O.
    Nephron; 1997 Nov 14; 77(2):176-85. PubMed ID: 9346384
    [Abstract] [Full Text] [Related]

  • 52. Verapamil reverts acute renal functional impairment induced by angiotensin II converting enzyme inhibitors.
    Macías-Núñez JF, Fernández R, Calvo C, Grande J, Herrera J, Bustamante J, Garay R, Robles R, López-Novoa JM.
    Ren Fail; 2003 Sep 14; 25(5):727-37. PubMed ID: 14575281
    [Abstract] [Full Text] [Related]

  • 53. Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.
    King JN, Font A, Rousselot JF, Ash RA, Bonfanti U, Brovida C, Crowe ID, Lanore D, Pechereau D, Seewald W, Strehlau G.
    J Vet Intern Med; 2017 Jul 14; 31(4):1113-1122. PubMed ID: 28669137
    [Abstract] [Full Text] [Related]

  • 54. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.
    Mizutani H, Koyama H, Watanabe T, Kitagawa H, Nakano M, Kajiwara K, King JN.
    J Vet Intern Med; 2006 Jul 14; 20(5):1074-9. PubMed ID: 17063698
    [Abstract] [Full Text] [Related]

  • 55. [Clinical observation on treatment of diabetic nephropathy with Chinese drugs combined with benazepril].
    Wang YZ, Wang XX, Wang HC.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug 14; 27(8):683-5. PubMed ID: 17879527
    [Abstract] [Full Text] [Related]

  • 56. Comparison of the effects of an ACE inhibitor and alphabeta blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report.
    Suzuki H, Moriwaki K, Kanno Y, Nakamoto H, Okada H, Chen XM.
    Hypertens Res; 2001 Mar 14; 24(2):153-8. PubMed ID: 11325074
    [Abstract] [Full Text] [Related]

  • 57. The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.
    Hanzlicek AS, Roof CJ, Sanderson MW, Grauer GF.
    J Vet Intern Med; 2014 Mar 14; 28(4):1221-8. PubMed ID: 24773179
    [Abstract] [Full Text] [Related]

  • 58. [Clinical observation on effect of shenle capsule in treating mesangial proliferating glomerulonephritis].
    Wei CY, Chen XM, Zhang YP.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May 14; 22(5):341-5. PubMed ID: 12584830
    [Abstract] [Full Text] [Related]

  • 59. Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure.
    Cohen DS, Mathis JE, Dotson RA, Graybill SR, Wosu NJ.
    J Cardiovasc Pharmacol; 1998 Jul 14; 32(1):87-95. PubMed ID: 9676726
    [Abstract] [Full Text] [Related]

  • 60. Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study.
    Jackevicius CA, Wong J, Aroustamian I, Gee M, Mody FV.
    BMJ Open; 2014 Jul 14; 4(8):e005181. PubMed ID: 25232564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.